VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma
2018 · BMC Cancer · 90 citations
https://doi.org/10.1186/s12885-018-4435-1
L
Li‐Xu Yan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
6.0K
Citations
33
h-index
53
i10-index
Li‐Xu Yan is an academic researcher from Central South University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 33, co-authored 116 publications.
ORCID: 0000-0002-5584-4265Papers by this author
worksEpstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma
2010 · Journal of Translational Medicine · 75 citations
https://doi.org/10.1186/1479-5876-8-30
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
2025 · Cell · 71 citations
https://doi.org/10.1016/j.cell.2025.03.018
Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels
2016 · BMC Cancer · 37 citations
https://doi.org/10.1186/s12885-016-2827-7
WSSS4LUAD: Grand Challenge on Weakly-supervised Tissue Semantic Segmentation for Lung Adenocarcinoma
2022 · arXiv (Cornell University) · 25 citations
https://doi.org/10.48550/arxiv.2204.06455
Multi-scale pathology image texture signature is a prognostic factor for resectable lung adenocarcinoma: a multi-center, retrospective study
2022 · Journal of Translational Medicine · 18 citations
https://doi.org/10.1186/s12967-022-03777-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat